SKI Market

Indian Indices

Sensex

83,817.69 78.56
( 0.09%)

Global Indices

Nasdaq

49,263.38 -165.29
(-0.33%)

Dow Jones

6,939.76 -57.68
(-0.82%)

Hang Seng

54,378.12 -342.54
(-0.63%)

Nikkei 225

10,302.23 -39.33
(-0.38%)

Forex

USD-INR

90.33 -1.29
(-1.40%)

EUR-INR

106.65 -1.90
(-1.75%)

GBP-INR

123.60 -1.74
(-1.39%)

JPY-INR

0.58 -0.01
(-1.94%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alkem Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539523

INE540L01014

1142.874838

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ALKEM

30.5

68195.09

EPS(TTM)

Face Value()

Div & Yield %

187.01

0.79

Back

Capri Global Capital consolidated net profit rises 143.35% in the September 2025 quarter

Oct 30,2025

Net profit of Capri Global Capital rose 143.35% to Rs 236.00 crore in the quarter ended September 2025 as against Rs 96.98 crore during the previous quarter ended September 2024. Sales rose 47.44% to Rs 1085.53 crore in the quarter ended September 2025 as against Rs 736.26 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1085.53	736.26	47
OPM %	68.50	62.90	-
PBDT	340.17	153.26	122
PBT	314.09	128.27	145
NP	236.00	96.98	143

83,817.69 78.56 ( 0.09%)

49,263.38 -165.29 (-0.33%)

6,939.76 -57.68 (-0.82%)

54,378.12 -342.54 (-0.63%)

10,302.23 -39.33 (-0.38%)

90.33 -1.29 (-1.40%)

106.65 -1.90 (-1.75%)

123.60 -1.74 (-1.39%)

0.58 -0.01 (-1.94%)